Nancy A. Simonian, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 37,070 shares at $0.27 ($10K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Seasonal sale ($10k) by Director — this insider has traded SYRS in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MLNM | SELL | 2008-03-07 | $234K | — | Filing → |
| MLNM | SELL | 2008-03-04 | $69K | — | Filing → |
| MLNM | SELL | 2007-12-14 | $1.7M | — | Filing → |